Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

v3.3.1.900
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Revenues:      
License and collaborative fees $ 49,064 $ 5,683 $ 11,028
Contract and other 6,383 13,183 24,423
Total revenues 55,447 18,866 35,451
Operating expenses:      
Research and development 70,852 80,748 74,851
Selling, general and administrative 20,620 19,866 18,477
Restructuring 3,699 84 328
Total operating expenses 95,171 100,698 93,656
Loss from operations (39,724) (81,832) (58,205)
Other income (expense):      
Interest expense (4,194) (4,303) (4,631)
Other income (expense), net 5,500 2,061 (197)
Revaluation of contingent warrant liabilities 17,812 45,773 (61,039)
Loss before taxes (20,606) (38,301) (124,072)
Benefit from income taxes     14
Net loss $ (20,606) $ (38,301) $ (124,058)
Basic net loss per share of common stock (in dollars per share) $ (0.17) $ (0.36) $ (1.43)
Diluted net loss per share of common stock (in dollars per share) $ (0.17) $ (0.67) $ (1.43)
Shares used in computing basic net loss per share of common stock (in shares) 117,803 107,435 86,938
Shares used in computing diluted net loss per share of common stock (in shares) 117,803 115,333 86,938
Other comprehensive loss:      
Net loss $ (20,606) $ (38,301) $ (124,058)
Net unrealized (loss) gain on available-for-sale securities   1 (9)
Comprehensive loss $ (20,606) $ (38,300) $ (124,067)